Simon is PlaqueTec’s GM and is responsible for the company’s clinical trial programs and business development. His commitment to enhance care in cardiovascular disease through the work PlaqueTec is doing follows medical and surgical practice in the UK before joining industry in 2010. Simon is a registered physician and member of the faculty of pharmaceutical medicine and the royal college of surgeons in the UK.